Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Panel Gives Thumbs-Up To Amgen's Virus-Based Melanoma Drug
FDA Panel Gives Thumbs-Up To Amgen's Virus-Based Melanoma Drug
FDA Panel Gives Thumbs-Up To Amgen's Virus-Based Melanoma Drug
Submitted by
admin
on April 29, 2015 - 6:31pm
Source:
Forbes
News Tags:
FDA
Amgen
melanoma
Talimogene Laherparepvec
T-Vec
Headline:
FDA Panel Gives Thumbs-Up To Amgen's Virus-Based Melanoma Drug
Do Not Allow Advertisers to Use My Personal information
